Showing results (21-30 of 257) with videos related to
Sort By:
Pageof 26
Pathology, Research and Practice|December 1, 1987
Prognostic factors in borderline and invasive ovarian tumors of the common epithelial typeJ P Baak, K K Chan, J G Stolk, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 17, 2004
Pulsed estrogen exposure selectively modulates tissue response: a hypothesisP Kenemans, A R Genazzani, S Palacios, et al.Clinical Chemistry|December 1, 1993
Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serumP Kenemans, G J van Kamp, P Oehr, et al.Maturitas|August 28, 1999
Hormone replacement therapy in women treated for gynaecological malignancyC W Burger, F E van Leeuwen, F Scheele, et al.Cancer Causes & Control : CCC|June 8, 2000
Cancer risk associated with subfertility and ovulation induction: a reviewH Klip, C W Burger, P Kenemans, et al.Anticancer Research|March 1, 1997
The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical applicationE M Schutter, C Mulder, G J van Kamp, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 1, 1997
Hormone replacement therapy and cardioprotection: basic concepts and clinical considerationsA Pines, V Mijatovic, M J van der Mooren, et al.Journal of Virology|March 1, 1971
Absence of interference during high-multiplicity infection by clonally purified vesicular stomatitis virusM Stampfer, D Baltimore, A S HuangScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1995
Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologistsJ Hilgers, S von Mensdorff-Pouilly, A A Verstraeten, et al.Journal of Clinical Pathology|July 1, 1995
Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissueM R Buist, C F Molthoff, P Kenemans, et al.Pageof 26